0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
Published Date: 2025-12-29
|
Report Code: QYRE-Auto-24N17488
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
BUY CHAPTERS

Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025

Code: QYRE-Auto-24N17488
Report
2025-12-29
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy Supply Chain Solution Market

The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell and Gene Therapy Supply Chain Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell and Gene Therapy Supply Chain Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell and Gene Therapy Supply Chain Solution in Biotech and Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell and Gene Therapy Supply Chain Solution include Cencora, Inc(World Courier), QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, Biocair, time:matters, Mercury Business Services, Cardinal Health, CRYOPDP, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Supply Chain Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Supply Chain Solution.
The Cell and Gene Therapy Supply Chain Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Supply Chain Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Supply Chain Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Gene Therapy Supply Chain Solution Market Report

Report Metric Details
Report Name Cell and Gene Therapy Supply Chain Solution Market
Segment by Type
  • Courier Company Provided
  • Hosted Logistics Company Provided
Segment by Application
  • Biotech and Pharmaceutical Companies
  • Hospitals
  • Research Organizations
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cencora, Inc(World Courier), QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, Biocair, time:matters, Mercury Business Services, Cardinal Health, CRYOPDP, Cryoport, NMDP BioTherapies, McKesson, Excel Courier, Almac, BEAM Logistics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Gene Therapy Supply Chain Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Supply Chain Solution Market report?

Ans: The main players in the Cell and Gene Therapy Supply Chain Solution Market are Cencora, Inc(World Courier), QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, Biocair, time:matters, Mercury Business Services, Cardinal Health, CRYOPDP, Cryoport, NMDP BioTherapies, McKesson, Excel Courier, Almac, BEAM Logistics

What are the Application segmentation covered in the Cell and Gene Therapy Supply Chain Solution Market report?

Ans: The Applications covered in the Cell and Gene Therapy Supply Chain Solution Market report are Biotech and Pharmaceutical Companies, Hospitals, Research Organizations, Other

What are the Type segmentation covered in the Cell and Gene Therapy Supply Chain Solution Market report?

Ans: The Types covered in the Cell and Gene Therapy Supply Chain Solution Market report are Courier Company Provided, Hosted Logistics Company Provided

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Courier Company Provided
1.2.3 Hosted Logistics Company Provided
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Supply Chain Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotech and Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Research Organizations
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Supply Chain Solution Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Supply Chain Solution Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Supply Chain Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Supply Chain Solution Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Supply Chain Solution Market Dynamics
2.3.1 Cell and Gene Therapy Supply Chain Solution Industry Trends
2.3.2 Cell and Gene Therapy Supply Chain Solution Market Drivers
2.3.3 Cell and Gene Therapy Supply Chain Solution Market Challenges
2.3.4 Cell and Gene Therapy Supply Chain Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Supply Chain Solution Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Supply Chain Solution Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Supply Chain Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Supply Chain Solution Revenue
3.4 Global Cell and Gene Therapy Supply Chain Solution Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Supply Chain Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Supply Chain Solution Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Supply Chain Solution Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Supply Chain Solution, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Supply Chain Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Supply Chain Solution Breakdown Data by Type
4.1 Global Cell and Gene Therapy Supply Chain Solution Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Supply Chain Solution Breakdown Data by Application
5.1 Global Cell and Gene Therapy Supply Chain Solution Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Supply Chain Solution Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Supply Chain Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Supply Chain Solution Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Supply Chain Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Supply Chain Solution Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Supply Chain Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cencora, Inc(World Courier)
11.1.1 Cencora, Inc(World Courier) Company Details
11.1.2 Cencora, Inc(World Courier) Business Overview
11.1.3 Cencora, Inc(World Courier) Cell and Gene Therapy Supply Chain Solution Introduction
11.1.4 Cencora, Inc(World Courier) Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.1.5 Cencora, Inc(World Courier) Recent Development
11.2 QuickStat
11.2.1 QuickStat Company Details
11.2.2 QuickStat Business Overview
11.2.3 QuickStat Cell and Gene Therapy Supply Chain Solution Introduction
11.2.4 QuickStat Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.2.5 QuickStat Recent Development
11.3 Associated Couriers, LLC
11.3.1 Associated Couriers, LLC Company Details
11.3.2 Associated Couriers, LLC Business Overview
11.3.3 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Introduction
11.3.4 Associated Couriers, LLC Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.3.5 Associated Couriers, LLC Recent Development
11.4 Central Pharma
11.4.1 Central Pharma Company Details
11.4.2 Central Pharma Business Overview
11.4.3 Central Pharma Cell and Gene Therapy Supply Chain Solution Introduction
11.4.4 Central Pharma Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.4.5 Central Pharma Recent Development
11.5 POLAR EXPRES
11.5.1 POLAR EXPRES Company Details
11.5.2 POLAR EXPRES Business Overview
11.5.3 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Introduction
11.5.4 POLAR EXPRES Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.5.5 POLAR EXPRES Recent Development
11.6 Biocair
11.6.1 Biocair Company Details
11.6.2 Biocair Business Overview
11.6.3 Biocair Cell and Gene Therapy Supply Chain Solution Introduction
11.6.4 Biocair Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.6.5 Biocair Recent Development
11.7 time:matters
11.7.1 time:matters Company Details
11.7.2 time:matters Business Overview
11.7.3 time:matters Cell and Gene Therapy Supply Chain Solution Introduction
11.7.4 time:matters Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.7.5 time:matters Recent Development
11.8 Mercury Business Services
11.8.1 Mercury Business Services Company Details
11.8.2 Mercury Business Services Business Overview
11.8.3 Mercury Business Services Cell and Gene Therapy Supply Chain Solution Introduction
11.8.4 Mercury Business Services Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.8.5 Mercury Business Services Recent Development
11.9 Cardinal Health
11.9.1 Cardinal Health Company Details
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Cell and Gene Therapy Supply Chain Solution Introduction
11.9.4 Cardinal Health Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.9.5 Cardinal Health Recent Development
11.10 CRYOPDP
11.10.1 CRYOPDP Company Details
11.10.2 CRYOPDP Business Overview
11.10.3 CRYOPDP Cell and Gene Therapy Supply Chain Solution Introduction
11.10.4 CRYOPDP Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.10.5 CRYOPDP Recent Development
11.11 Cryoport
11.11.1 Cryoport Company Details
11.11.2 Cryoport Business Overview
11.11.3 Cryoport Cell and Gene Therapy Supply Chain Solution Introduction
11.11.4 Cryoport Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.11.5 Cryoport Recent Development
11.12 NMDP BioTherapies
11.12.1 NMDP BioTherapies Company Details
11.12.2 NMDP BioTherapies Business Overview
11.12.3 NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Introduction
11.12.4 NMDP BioTherapies Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.12.5 NMDP BioTherapies Recent Development
11.13 McKesson
11.13.1 McKesson Company Details
11.13.2 McKesson Business Overview
11.13.3 McKesson Cell and Gene Therapy Supply Chain Solution Introduction
11.13.4 McKesson Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.13.5 McKesson Recent Development
11.14 Excel Courier
11.14.1 Excel Courier Company Details
11.14.2 Excel Courier Business Overview
11.14.3 Excel Courier Cell and Gene Therapy Supply Chain Solution Introduction
11.14.4 Excel Courier Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.14.5 Excel Courier Recent Development
11.15 Almac
11.15.1 Almac Company Details
11.15.2 Almac Business Overview
11.15.3 Almac Cell and Gene Therapy Supply Chain Solution Introduction
11.15.4 Almac Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.15.5 Almac Recent Development
11.16 BEAM Logistics
11.16.1 BEAM Logistics Company Details
11.16.2 BEAM Logistics Business Overview
11.16.3 BEAM Logistics Cell and Gene Therapy Supply Chain Solution Introduction
11.16.4 BEAM Logistics Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
11.16.5 BEAM Logistics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Courier Company Provided
 Table 3. Key Players of Hosted Logistics Company Provided
 Table 4. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cell and Gene Therapy Supply Chain Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell and Gene Therapy Supply Chain Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cell and Gene Therapy Supply Chain Solution Market Share by Region (2020-2025)
 Table 8. Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cell and Gene Therapy Supply Chain Solution Market Share by Region (2026-2031)
 Table 10. Cell and Gene Therapy Supply Chain Solution Market Trends
 Table 11. Cell and Gene Therapy Supply Chain Solution Market Drivers
 Table 12. Cell and Gene Therapy Supply Chain Solution Market Challenges
 Table 13. Cell and Gene Therapy Supply Chain Solution Market Restraints
 Table 14. Global Cell and Gene Therapy Supply Chain Solution Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cell and Gene Therapy Supply Chain Solution Market Share by Players (2020-2025)
 Table 16. Global Top Cell and Gene Therapy Supply Chain Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain Solution as of 2024)
 Table 17. Ranking of Global Top Cell and Gene Therapy Supply Chain Solution Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy Supply Chain Solution Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cell and Gene Therapy Supply Chain Solution, Headquarters and Area Served
 Table 20. Global Key Players of Cell and Gene Therapy Supply Chain Solution, Product and Application
 Table 21. Global Key Players of Cell and Gene Therapy Supply Chain Solution, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Type (2020-2025)
 Table 25. Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Type (2026-2031)
 Table 27. Global Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Application (2020-2025)
 Table 29. Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Application (2026-2031)
 Table 31. North America Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Cencora, Inc(World Courier) Company Details
 Table 47. Cencora, Inc(World Courier) Business Overview
 Table 48. Cencora, Inc(World Courier) Cell and Gene Therapy Supply Chain Solution Product
 Table 49. Cencora, Inc(World Courier) Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 50. Cencora, Inc(World Courier) Recent Development
 Table 51. QuickStat Company Details
 Table 52. QuickStat Business Overview
 Table 53. QuickStat Cell and Gene Therapy Supply Chain Solution Product
 Table 54. QuickStat Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 55. QuickStat Recent Development
 Table 56. Associated Couriers, LLC Company Details
 Table 57. Associated Couriers, LLC Business Overview
 Table 58. Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Product
 Table 59. Associated Couriers, LLC Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 60. Associated Couriers, LLC Recent Development
 Table 61. Central Pharma Company Details
 Table 62. Central Pharma Business Overview
 Table 63. Central Pharma Cell and Gene Therapy Supply Chain Solution Product
 Table 64. Central Pharma Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 65. Central Pharma Recent Development
 Table 66. POLAR EXPRES Company Details
 Table 67. POLAR EXPRES Business Overview
 Table 68. POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Product
 Table 69. POLAR EXPRES Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 70. POLAR EXPRES Recent Development
 Table 71. Biocair Company Details
 Table 72. Biocair Business Overview
 Table 73. Biocair Cell and Gene Therapy Supply Chain Solution Product
 Table 74. Biocair Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 75. Biocair Recent Development
 Table 76. time:matters Company Details
 Table 77. time:matters Business Overview
 Table 78. time:matters Cell and Gene Therapy Supply Chain Solution Product
 Table 79. time:matters Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 80. time:matters Recent Development
 Table 81. Mercury Business Services Company Details
 Table 82. Mercury Business Services Business Overview
 Table 83. Mercury Business Services Cell and Gene Therapy Supply Chain Solution Product
 Table 84. Mercury Business Services Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 85. Mercury Business Services Recent Development
 Table 86. Cardinal Health Company Details
 Table 87. Cardinal Health Business Overview
 Table 88. Cardinal Health Cell and Gene Therapy Supply Chain Solution Product
 Table 89. Cardinal Health Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 90. Cardinal Health Recent Development
 Table 91. CRYOPDP Company Details
 Table 92. CRYOPDP Business Overview
 Table 93. CRYOPDP Cell and Gene Therapy Supply Chain Solution Product
 Table 94. CRYOPDP Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 95. CRYOPDP Recent Development
 Table 96. Cryoport Company Details
 Table 97. Cryoport Business Overview
 Table 98. Cryoport Cell and Gene Therapy Supply Chain Solution Product
 Table 99. Cryoport Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 100. Cryoport Recent Development
 Table 101. NMDP BioTherapies Company Details
 Table 102. NMDP BioTherapies Business Overview
 Table 103. NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Product
 Table 104. NMDP BioTherapies Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 105. NMDP BioTherapies Recent Development
 Table 106. McKesson Company Details
 Table 107. McKesson Business Overview
 Table 108. McKesson Cell and Gene Therapy Supply Chain Solution Product
 Table 109. McKesson Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 110. McKesson Recent Development
 Table 111. Excel Courier Company Details
 Table 112. Excel Courier Business Overview
 Table 113. Excel Courier Cell and Gene Therapy Supply Chain Solution Product
 Table 114. Excel Courier Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 115. Excel Courier Recent Development
 Table 116. Almac Company Details
 Table 117. Almac Business Overview
 Table 118. Almac Cell and Gene Therapy Supply Chain Solution Product
 Table 119. Almac Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 120. Almac Recent Development
 Table 121. BEAM Logistics Company Details
 Table 122. BEAM Logistics Business Overview
 Table 123. BEAM Logistics Cell and Gene Therapy Supply Chain Solution Product
 Table 124. BEAM Logistics Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
 Table 125. BEAM Logistics Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Cell and Gene Therapy Supply Chain Solution Picture
 Figure 2. Global Cell and Gene Therapy Supply Chain Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell and Gene Therapy Supply Chain Solution Market Share by Type: 2024 VS 2031
 Figure 4. Courier Company Provided Features
 Figure 5. Hosted Logistics Company Provided Features
 Figure 6. Global Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cell and Gene Therapy Supply Chain Solution Market Share by Application: 2024 VS 2031
 Figure 8. Biotech and Pharmaceutical Companies Case Studies
 Figure 9. Hospitals Case Studies
 Figure 10. Research Organizations Case Studies
 Figure 11. Other Case Studies
 Figure 12. Cell and Gene Therapy Supply Chain Solution Report Years Considered
 Figure 13. Global Cell and Gene Therapy Supply Chain Solution Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cell and Gene Therapy Supply Chain Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cell and Gene Therapy Supply Chain Solution Market Share by Region: 2024 VS 2031
 Figure 16. Global Cell and Gene Therapy Supply Chain Solution Market Share by Players in 2024
 Figure 17. Global Top Cell and Gene Therapy Supply Chain Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain Solution as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Supply Chain Solution Revenue in 2024
 Figure 19. North America Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cell and Gene Therapy Supply Chain Solution Market Share by Country (2020-2031)
 Figure 21. United States Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cell and Gene Therapy Supply Chain Solution Market Share by Country (2020-2031)
 Figure 25. Germany Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Share by Region (2020-2031)
 Figure 33. China Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cell and Gene Therapy Supply Chain Solution Market Share by Country (2020-2031)
 Figure 41. Mexico Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Share by Country (2020-2031)
 Figure 45. Turkey Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cell and Gene Therapy Supply Chain Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Cencora, Inc(World Courier) Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 49. QuickStat Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 50. Associated Couriers, LLC Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 51. Central Pharma Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 52. POLAR EXPRES Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 53. Biocair Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 54. time:matters Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 55. Mercury Business Services Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 56. Cardinal Health Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 57. CRYOPDP Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 58. Cryoport Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 59. NMDP BioTherapies Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 60. McKesson Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 61. Excel Courier Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 62. Almac Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 63. BEAM Logistics Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS